Back
Results - Announcements
Sunil Healthcare Ltd consolidated sales down 3.70% on year in Q2FY2026, net profit tanked by 69.74%
13-Aug-2026, 10:25
Sunil Healthcare Ltd share price declined by 1.43% to Rs 70.78 after the company's net profit plunged by 69.74% to Rs 0.46 crore, while revenue from operations softened by 3.70% to Rs 18.99 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, gaining 4.61%. It has inched up 0.99% over last one week and advanced by 11.20% in last one month while the market capitalization of Sunil Healthcare Ltd has improved by 2.54% and 11.28% in the same period respectively. Profit before tax (PBT) of Sunil Healthcare Ltd stood at Rs 0.2 crore in Q2 FY26, crashing by 80.58% year-on-year, and tumbling by 121.05% quarter-on-quarter. EBITDA came in at Rs 3 crore, heading higher 11.57% YoY and expanding by 76.47% sequentially. Total expenses marginally dropped 9.22% to Rs 17.52 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 9.43 crore, jumping 61.75% YoY, while employee benefits expense was at Rs 3.17 crore, easing 1.60% YoY. For the TTM ended FY26, revenue from operations declined slightly by 7.51% to Rs 83.42 crore, while net profit witnessed a sharp fall of 20.67% to Rs 1.42 crore, compared to previous TTM. EBITDA tumbled by 187% to Rs 8.92 crore, and PBT collapsed by 52.34% to Rs 1.22 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 11.52 crore in FY26, as against Rs 15.4 crore in FY25. Sunil Healthcare Ltd retreated by 6.36% in last one year, significantly underperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.
Sunil Healthcare Ltd share price declined by 1.43% to Rs 70.78 after the company's net profit plunged by 69.74% to Rs 0.46 crore, while revenue from operations softened by 3.70% to Rs 18.99 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, gaining 4.61%. It has inched up 0.99% over last one week and advanced by 11.20% in last one month while the market capitalization of Sunil Healthcare Ltd has improved by 2.54% and 11.28% in the same period respectively. Profit before tax (PBT) of Sunil Healthcare Ltd stood at Rs 0.2 crore in Q2 FY26, crashing by 80.58% year-on-year, and tumbling by 121.05% quarter-on-quarter. EBITDA came in at Rs 3 crore, heading higher 11.57% YoY and expanding by 76.47% sequentially. Total expenses marginally dropped 9.22% to Rs 17.52 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 9.43 crore, jumping 61.75% YoY, while employee benefits expense was at Rs 3.17 crore, easing 1.60% YoY. For the TTM ended FY26, revenue from operations declined slightly by 7.51% to Rs 83.42 crore, while net profit witnessed a sharp fall of 20.67% to Rs 1.42 crore, compared to previous TTM. EBITDA tumbled by 187% to Rs 8.92 crore, and PBT collapsed by 52.34% to Rs 1.22 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 11.52 crore in FY26, as against Rs 15.4 crore in FY25. Sunil Healthcare Ltd retreated by 6.36% in last one year, significantly underperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.